{ "company_number": "08868139", "name": "Espee Pharma (UK) Limited", "url": "/company/08868139", "status": "Active", "is_active": true, "company_type": "Private Limited Company", "incorporated_on": "2014-01-30", "dissolved_on": null, "sic_codes": [ { "code": "47730", "description": "Dispensing chemist in specialised stores", "section": "G", "section_name": "Wholesale and retail trade; repair of motor vehicles and motorcycles", "url": "/sic/47730" } ], "registered_address": { "id": 2237756, "url": "/address/2237756", "line1": "UNIT 1 CONQUEROR COURT", "line2": "SPILSBY ROAD HAROLD HILL", "post_town": "ROMFORD", "county": "ESSEX", "country": "", "postcode": "RM3 8SB" }, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/08868139", "previous_names": [], "care_of": "", "po_box": "", "country_of_origin": "United Kingdom", "accounts": { "next_due": "2027-03-31", "last_made_up": "2025-06-30", "category": "TOTAL EXEMPTION FULL", "filings": [ { "url": "/company/08868139/accounts/2025-06-30", "pdf_url": "/company/08868139/accounts/2025-06-30.pdf", "made_up_date": "2025-06-30", "period_start": "2025-06-30", "period_end": "2025-06-30", "entity_name": "Espee Pharma (UK) Limited", "dormant": false, "average_employees": "3.00", "tangible_fixed_assets": "24395.00", "debtors": "152701.00", "cash_bank_in_hand": "352158.00", "current_assets": "604248.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "326671.00", "total_assets_less_current_liabilities": "351066.00", "net_assets_liabilities": "351066.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "350966.00", "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Bulk_Data-2026-07-01.zip" }, { "url": "/company/08868139/accounts/2024-06-30", "pdf_url": "/company/08868139/accounts/2024-06-30.pdf", "made_up_date": "2024-06-30", "period_start": "2023-07-01", "period_end": "2024-06-30", "entity_name": "Espee Pharma (UK) Limited", "dormant": false, "average_employees": "3.00", "tangible_fixed_assets": "538.00", "debtors": "268022.00", "cash_bank_in_hand": "583743.00", "current_assets": "995499.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "299322.00", "total_assets_less_current_liabilities": "299860.00", "net_assets_liabilities": "299860.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "299760.00", "shareholder_funds": "100.00", "turnover": "4376643.00", "other_operating_income": null, "cost_sales": "3771331.00", "gross_profit_loss": "605312.00", "administrative_expenses": "520225.00", "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": "85087.00", "profit_before_tax": "62294.00", "tax_on_profit": "12758.00", "profit_loss_for_period": "49536.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-April2025.zip" }, { "url": "/company/08868139/accounts/2023-06-30", "pdf_url": "/company/08868139/accounts/2023-06-30.pdf", "made_up_date": "2023-06-30", "period_start": "2022-07-01", "period_end": "2023-06-30", "entity_name": "Espee Pharma (UK) Limited", "dormant": false, "average_employees": "3.00", "tangible_fixed_assets": "538.00", "debtors": "122851.00", "cash_bank_in_hand": "222355.00", "current_assets": "464571.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "328666.00", "total_assets_less_current_liabilities": "329204.00", "net_assets_liabilities": "250324.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "250224.00", "shareholder_funds": "100.00", "turnover": "2072542.00", "other_operating_income": null, "cost_sales": "1804016.00", "gross_profit_loss": "268526.00", "administrative_expenses": "240941.00", "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": "27585.00", "tax_on_profit": "5275.00", "profit_loss_for_period": "22310.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-May2024.zip" }, { "url": "/company/08868139/accounts/2022-06-30", "pdf_url": "/company/08868139/accounts/2022-06-30.pdf", "made_up_date": "2022-06-30", "period_start": "2021-07-01", "period_end": "2022-06-30", "entity_name": "Espee Pharma (UK) Limited", "dormant": false, "average_employees": "3.00", "tangible_fixed_assets": "717.00", "debtors": "218262.00", "cash_bank_in_hand": "298331.00", "current_assets": "580693.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "417980.00", "total_assets_less_current_liabilities": "418697.00", "net_assets_liabilities": "228014.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "227914.00", "shareholder_funds": "100.00", "turnover": "2649049.00", "other_operating_income": null, "cost_sales": "2337064.00", "gross_profit_loss": "311985.00", "administrative_expenses": "263001.00", "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": "48984.00", "tax_on_profit": "10031.00", "profit_loss_for_period": "38953.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2023.zip" }, { "url": "/company/08868139/accounts/2021-06-30", "pdf_url": "/company/08868139/accounts/2021-06-30.pdf", "made_up_date": "2021-06-30", "period_start": "2020-07-01", "period_end": "2021-06-30", "entity_name": "Espee Pharma (UK) Limited", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "956.00", "debtors": "20571.00", "cash_bank_in_hand": "448651.00", "current_assets": "512151.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "398056.00", "total_assets_less_current_liabilities": "399012.00", "net_assets_liabilities": "189061.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100.00", "turnover": "3098403.00", "other_operating_income": null, "cost_sales": "2860944.00", "gross_profit_loss": "237459.00", "administrative_expenses": "196380.00", "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": "39281.00", "profit_before_tax": "39281.00", "tax_on_profit": "8886.00", "profit_loss_for_period": "30395.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2022.zip" }, { "url": "/company/08868139/accounts/2020-06-30", "pdf_url": "/company/08868139/accounts/2020-06-30.pdf", "made_up_date": "2020-06-30", "period_start": "2019-07-01", "period_end": "2020-06-30", "entity_name": "Espee Pharma (UK) Limited", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "1275.00", "debtors": "392659.00", "cash_bank_in_hand": "87753.00", "current_assets": "543901.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "167341.00", "total_assets_less_current_liabilities": "168616.00", "net_assets_liabilities": "158666.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100.00", "turnover": "1984564.00", "other_operating_income": null, "cost_sales": "1671905.00", "gross_profit_loss": "312659.00", "administrative_expenses": "260099.00", "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": "32851.00", "profit_before_tax": "32741.00", "tax_on_profit": "6352.00", "profit_loss_for_period": "26389.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2021.zip" }, { "url": "/company/08868139/accounts/2019-06-30", "pdf_url": "/company/08868139/accounts/2019-06-30.pdf", "made_up_date": "2019-06-30", "period_start": "2018-07-01", "period_end": "2019-06-30", "entity_name": "Espee Pharma (UK) Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "1700.00", "debtors": "319230.00", "cash_bank_in_hand": "56212.00", "current_assets": "440349.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "130576.00", "total_assets_less_current_liabilities": "132276.00", "net_assets_liabilities": "132276.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100.00", "turnover": "2310064.00", "other_operating_income": null, "cost_sales": "2014970.00", "gross_profit_loss": "295094.00", "administrative_expenses": "206373.00", "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": "76986.00", "profit_before_tax": "76960.00", "tax_on_profit": "14730.00", "profit_loss_for_period": "62230.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2020.zip" }, { "url": "/company/08868139/accounts/2018-06-30", "pdf_url": "/company/08868139/accounts/2018-06-30.pdf", "made_up_date": "2018-06-30", "period_start": "2017-07-01", "period_end": "2018-06-30", "entity_name": "Espee Pharma (UK) Limited", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "2265.00", "debtors": "284952.00", "cash_bank_in_hand": "83199.00", "current_assets": "413446.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "137731.00", "total_assets_less_current_liabilities": "139996.00", "net_assets_liabilities": "120046.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100.00", "turnover": "2059282.00", "other_operating_income": null, "cost_sales": "1628526.00", "gross_profit_loss": "430756.00", "administrative_expenses": "232803.00", "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": "197953.00", "profit_before_tax": "197965.00", "tax_on_profit": "37253.00", "profit_loss_for_period": "160712.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-March2019.zip" }, { "url": "/company/08868139/accounts/2017-06-30", "pdf_url": "/company/08868139/accounts/2017-06-30.pdf", "made_up_date": "2017-06-30", "period_start": "2016-07-01", "period_end": "2017-06-30", "entity_name": "Espee Pharma (UK) Limited", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "370.00", "debtors": "120316.00", "cash_bank_in_hand": "136122.00", "current_assets": "322532.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "58914.00", "total_assets_less_current_liabilities": "59284.00", "net_assets_liabilities": "39334.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100.00", "turnover": "708900.00", "other_operating_income": null, "cost_sales": "460001.00", "gross_profit_loss": "248899.00", "administrative_expenses": "162009.00", "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": "86890.00", "profit_before_tax": "86903.00", "tax_on_profit": "17188.00", "profit_loss_for_period": "69715.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-March2018.zip" }, { "url": "/company/08868139/accounts/2016-06-30", "pdf_url": "/company/08868139/accounts/2016-06-30.pdf", "made_up_date": "2016-06-30", "period_start": "2016-06-30", "period_end": "2016-06-30", "entity_name": "Espee Pharma (UK) Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "493.00", "debtors": "33865.00", "cash_bank_in_hand": "105321.00", "current_assets": "157843.00", "creditors_due_within_one_year": "128767.00", "creditors_due_after_one_year": "19950.00", "net_current_assets_liabilities": "29076.00", "total_assets_less_current_liabilities": "29569.00", "net_assets_liabilities": "9619.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "9519.00", "shareholder_funds": "9619.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-March2017.zip" }, { "url": "/company/08868139/accounts/2015-06-30", "pdf_url": "/company/08868139/accounts/2015-06-30.pdf", "made_up_date": "2015-06-30", "period_start": "2015-06-30", "period_end": "2015-06-30", "entity_name": "Espee Pharma (UK) Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": "46250.00", "cash_bank_in_hand": "17618.00", "current_assets": "90904.00", "creditors_due_within_one_year": "63498.00", "creditors_due_after_one_year": "19950.00", "net_current_assets_liabilities": "27406.00", "total_assets_less_current_liabilities": "27406.00", "net_assets_liabilities": "7456.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "7356.00", "shareholder_funds": "7456.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-October2015.zip" } ], "pdf_only_filings": [], "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/08868139/filing-history" }, "confirmation_statement": { "next_due": "2027-04-14", "last_made_up": "2026-03-31" }, "officers": [], "psc": [ { "name": "Espee Biopharma & Finechem Llc", "kind": "corporate-entity-person-with-significant-control", "person_url": null, "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent", "voting-rights-25-to-50-percent" ], "notified_on": "2016-04-06", "ceased_on": "2026-06-10", "nationality": "", "country_of_residence": "", "source": "snapshot" }, { "name": "Ric Chemicals Limited", "kind": "corporate-entity-person-with-significant-control", "person_url": null, "controlling_company_url": "/company/03091306", "natures_of_control": [ "ownership-of-shares-25-to-50-percent", "voting-rights-25-to-50-percent" ], "notified_on": "2016-04-06", "ceased_on": null, "nationality": "", "country_of_residence": "", "source": "snapshot" } ], "external_links": [], "provenance": { "source": "snapshot", "first_seen_at": "2026-07-05T12:35:35.811816+00:00", "last_seen_snapshot": "2026-09-01", "retrieved_at": "2026-09-27T03:24:04.087973+00:00" }, "licence": "Open Government Licence v3.0", "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House." }